These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7770607)

  • 1. Effects of the NMDA-antagonist, MK-801, on stress-induced alterations of dopamine dependent behavior.
    Mele A; Cabib S; Oliverio A
    Psychopharmacology (Berl); 1995 Feb; 117(3):313-7. PubMed ID: 7770607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice.
    Kim HS; Jang CG
    Brain Res Bull; 1997; 44(3):221-7. PubMed ID: 9323434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice.
    Nomikos GG; Mathé AA; Mathé JM; Svensson TH
    Psychopharmacology (Berl); 1992; 108(3):367-70. PubMed ID: 1387964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice.
    Kim HS; Rhee GS; Jung JY; Lee JH; Jang CG; Park WK
    Life Sci; 1996; 58(17):1397-402. PubMed ID: 8622565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response.
    Gancher S; Mayer A
    Brain Res; 1995 Jun; 682(1-2):63-8. PubMed ID: 7552328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA-type glutamatergic modulation in dopaminergic activation measured by apomorphine-induced cage climbing behaviors.
    Jang CG; Lee SY
    Arch Pharm Res; 2001 Dec; 24(6):613-7. PubMed ID: 11794545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
    Kim HS; Jang CG; Park WK
    Pharmacol Biochem Behav; 1996 Sep; 55(1):11-7. PubMed ID: 8870032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.
    Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1992; 107(4):591-4. PubMed ID: 1534911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems.
    Löscher W; Hönack D
    Eur J Pharmacol; 1992 May; 215(2-3):199-208. PubMed ID: 1356790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of MK-801 on contextual sensitization to climbing behavior and on development of tolerance to hypothermia induced by a single high dose of apomorphine.
    Yun JS; Kim HS; Lee MK; Oh KW; Jang CG; Park WK; Seong YH; Lee SC; Oh SK
    Pharmacol Res; 2001 Dec; 44(6):473-9. PubMed ID: 11735353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of behavioral sensitization to apomorphine is blocked by MK-801.
    Druhan JP; Jakob A; Stewart J
    Eur J Pharmacol; 1993 Oct; 243(1):73-7. PubMed ID: 8253127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors.
    Yap JJ; Covington HE; Gale MC; Datta R; Miczek KA
    Psychopharmacology (Berl); 2005 Apr; 179(1):230-9. PubMed ID: 15517195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance.
    Mele A; Castellano C; Oliverio A
    Psychopharmacology (Berl); 1995 Oct; 121(3):401-5. PubMed ID: 8584624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors.
    Corbett R; Camacho F; Woods AT; Kerman LL; Fishkin RJ; Brooks K; Dunn RW
    Psychopharmacology (Berl); 1995 Jul; 120(1):67-74. PubMed ID: 7480537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral sensitization to ethanol results in cross-sensitization to MK-801 but not to NMDA administered intra-accumbens.
    Abrahao KP; Souza-Formigoni ML
    Behav Brain Res; 2012 Dec; 235(2):218-24. PubMed ID: 22871257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
    Ferré S; Giménez-Llort L; Artigas F; Martínez E
    Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice.
    Kim HS; Park WK; Jang CG; Oh S
    Brain Res Bull; 1996; 40(3):201-7. PubMed ID: 8736582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-dependent effects of chronic stress on apomorphine-induced alterations of striatal and mesolimbic dopamine metabolism.
    Cabib S; Puglisi-Allegra S
    Brain Res; 1991 Feb; 542(1):91-6. PubMed ID: 2054663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.